The Life Path Health Group is a network of hospitals providing mental health inpatient treatment and addiction treatment in private facilities in the country. The mental health treatment provider currently operates in seven facilities concentrated in the Western Cape, with a further three in the process of development in other regions of South Africa.
“There is a strong alignment between Life Path Health’s current healthcare offering and Mediclinic’s vision of transforming into a more integrated healthcare service provider, offering a broader range of services to our patients,” said CEO of Mediclinic Southern Africa, Koert Pretorius.
CEO and founder of Life Path Healthcare, Anton Rossouw, added: “We see this as the next phase in our growth path and we value the positive investment from a sound business partner of Mediclinic’s calibre.”
Life Path Health is a well-recognised role player in the mental health environment and Mediclinic believes that this acquisition will fulfil their strategic objective of expanding the basket of care services available to the South African market, while also leveraging off the experience and track record offered by Life Path Health.
Life Path Health specialises in addiction rehabilitation; adjustment disorders; anxiety disorder; dementia; electro convulsive therapy; mood disorders such as depression; bipolar; obsessive compulsive disorders; panic disorders; post-traumatic stress disorders; and psychotic conditions including schizophrenia and psychotic mood disorders.
While it will form part of the Mediclinic offering, business will remain as is for the mental health provider with no planned structural or operational changes in the immediate future.
The acquisition of the majority stake in Life Path Health is subject to the fulfilment of a number of suspensive conditions, including the approval of the transaction by the Competition Authorities.